BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7668834)

  • 21. Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.
    Wozniak MA; Itzhaki RF; Faragher EB; James MW; Ryder SD; Irving WL;
    Hepatology; 2002 Aug; 36(2):456-63. PubMed ID: 12143056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
    Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
    Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does apolipoprotein E genotype modify the clinical expression of ALS?
    Jawaid A; Poon M; Strutt AM; Rice LK; McDowell EJ; Salamone AR; Qureshi SU; Simpson E; Appel SH; York MK; Schulz PE
    Eur J Neurol; 2011 Apr; 18(4):618-24. PubMed ID: 20880000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis.
    Zetterberg H; Jacobsson J; Rosengren L; Blennow K; Andersen PM
    J Neurol Sci; 2008 Oct; 273(1-2):67-9. PubMed ID: 18656208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis.
    Moulard B; Sefiani A; Laamri A; Malafosse A; Camu W
    J Neurol Sci; 1996 Aug; 139 Suppl():34-7. PubMed ID: 8899655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes.
    Buée L; Pérez-Tur J; Leveugle B; Buée-Scherrer V; Mufson EJ; Loerzel AJ; Chartier-Harlin MC; Perl DP; Delacourte A; Hof PR
    Acta Neuropathol; 1996; 91(3):247-53. PubMed ID: 8834536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
    Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
    Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis.
    Li YJ; Pericak-Vance MA; Haines JL; Siddique N; McKenna-Yasek D; Hung WY; Sapp P; Allen CI; Chen W; Hosler B; Saunders AM; Dellefave LM; Brown RH; Siddique T
    Neurogenetics; 2004 Dec; 5(4):209-13. PubMed ID: 15657798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of apolipoprotein E in patients with amyotrophic lateral sclerosis (a clinical and genetic study)].
    Kutakova EV; Zakharova MN; Illarioshkin SN; Kliushnikov SA; Zavalishin IA; Ivanova-Smolenskaia IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):51-4. PubMed ID: 19365373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.
    Sorbi S; Nacmias B; Forleo P; Latorraca S; Gobbini I; Bracco L; Piacentini S; Amaducci L
    Neurosci Lett; 1994 Aug; 177(1-2):100-2. PubMed ID: 7824157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset.
    Murman DL; Foster NL; Kilgore SP; McDonagh CA; Fink JK
    Dementia; 1996; 7(5):251-5. PubMed ID: 8872415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.
    Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Edwardson JA; Torvik A; Morris CM; Bjertness E
    Neurodegeneration; 1996 Mar; 5(1):43-7. PubMed ID: 8731381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China.
    Fang DF; Zhang SS; Guo XY; Zeng Y; Yang Y; Zhou D; Shang HF
    Amyotroph Lateral Scler; 2009; 10(5-6):350-4. PubMed ID: 19922123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration.
    Schultz DW; Klein ML; Humpert A; Majewski J; Schain M; Weleber RG; Ott J; Acott TS
    Arch Ophthalmol; 2003 May; 121(5):679-83. PubMed ID: 12742846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: a comprehensive meta-analysis.
    Govone F; Vacca A; Rubino E; Gai A; Boschi S; Gentile S; Orsi L; Pinessi L; Rainero I
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):551-6. PubMed ID: 24918518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis.
    Drory VE; Birnbaum M; Korczyn AD; Chapman J
    J Neurol Sci; 2001 Sep; 190(1-2):17-20. PubMed ID: 11574101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.
    Yoshizawa T; Yamakawa-Kobayashi K; Komatsuzaki Y; Arinami T; Oguni E; Mizusawa H; Shoji S; Hamaguchi H
    Ann Neurol; 1994 Oct; 36(4):656-9. PubMed ID: 7944299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hexosaminidase A activity and amyotrophic lateral sclerosis.
    Gudesblatt M; Ludman MD; Cohen JA; Desnick RJ; Chester S; Grabowski GA; Caroscio JT
    Muscle Nerve; 1988 Mar; 11(3):227-30. PubMed ID: 2965300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE ε4 allele is associated with an increased risk of bulbar-onset amyotrophic lateral sclerosis in men.
    Praline J; Blasco H; Vourc'h P; Garrigue MA; Gordon PH; Camu W; Corcia P; Andres CR;
    Eur J Neurol; 2011 Aug; 18(8):1046-52. PubMed ID: 21251163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis.
    Blauw HM; van Rheenen W; Koppers M; Van Damme P; Waibel S; Lemmens R; van Vught PW; Meyer T; Schulte C; Gasser T; Cuppen E; Pasterkamp RJ; Robberecht W; Ludolph AC; Veldink JH; van den Berg LH
    Hum Mol Genet; 2012 Jun; 21(11):2497-502. PubMed ID: 22378146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.